Search results for: Market Access
Filter search results
Sleepio: Lessons from the Frontier of Digital Therapeutics
31 May 2022
…out. The study was conducted in the Thames Valley region of England, and everybody in the area (with an eligible postcode) could access Sleepio for free between October 2018 and…
Data Governance Arrangements for Real-World Evidence
1 November 2015
The objective of this OHE Consulting Report was to understand and develop a view on the core principles that should govern how Real-World Data (RWD) is accessed or generated, and…
An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’
1 December 2016
…qualitatively assess documentation associated with RiLCP decisions to create a framework to describe common themes, and assess the level of patient access associated with each RiLCP decision. Between January 2007…
Reflections from the Region: Healthcare transformation in the Middle East
18 June 2025
…are already deeply embedded. Here, we see policymakers grappling with first principles: What does “value” mean in this context? How should evidence be weighted? What kind of access model aligns…
Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals
1 July 2018
…the implications for: payer budgets, patient access, and the incentives for innovation? Varying prices with the use of a drug offers the opportunity to better align payment with value, but…
Making Outcome-Based Payment a Reality in the NHS
2 January 2019
…accelerate patient access to some new medicines and ensure close monitoring of real-world patient benefit. OHE Research Paper 19/01: This report explores the feasibility of introducing one type of flexible…
The Future of Global Health Procurement: Issues around Pricing Transparency
1 March 2019
…markets are, however, dominated by generic products. Price transparency for off-patent products could improve market efficiency if capacities are there to use the data to inform procurement decisions. whilst protecting…
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
1 July 2019
…over the long-run to support consideration as to how access decisions can be informed by these life cycle effects. The present work aims to assess the life-cycle value of innovative…
Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
1 December 2021
…published the results of a research study describing how OBP could help accelerate patient access to some new medicines, ensure close monitoring of real-world patient benefits, promote value for money…